Literature DB >> 15611932

Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization.

Kylie L Gorringe1, Alex Boussioutas, David D L Bowtell.   

Abstract

Gastric cancer (GC) frequently displays changes in DNA copy number, but few studies have precisely correlated specific genetic alterations with changes in gene expression. We undertook both array comparative genomic hybridization (aCGH) and expression analyses of 20 primary GCs using a cDNA microarray with more than 9,300 genes. Diverse clinical and histopathologic tumor subtypes, including signet-ring tumors and tumors at the gastroesophageal junction, were analyzed. All tumors showed changes in gene copy number, with the majority showing multiple changes. Regions of gain and loss were generally consistent with previous cytogenetic reports; however, the use of aCGH greatly increased the resolution of measured genomic change. By comparing gene expression and high-resolution measurement of gene copy number directly, we were able to identify several regions of high-level gain associated with substantially increased gene expression that have not been defined previously in GC. Novel candidate oncogenes included dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) and protein tyrosine kinase 7 (PTK7).

Entities:  

Mesh:

Year:  2005        PMID: 15611932     DOI: 10.1002/gcc.20136

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  46 in total

1.  The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells.

Authors:  Hye-Won Na; Won-Sik Shin; Andreas Ludwig; Seung-Taek Lee
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.

Authors:  Orit Jacobson; Ido D Weiss; Lu Wang; Zhe Wang; Xiangyu Yang; Andrew Dewhurst; Ying Ma; Guizhi Zhu; Gang Niu; Dale O Kiesewetter; Neil Vasdev; Steven H Liang; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-08-27       Impact factor: 10.057

3.  Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors.

Authors:  Shanta M Messerli; Mariah M Hoffman; Etienne Z Gnimpieba; Ratan D Bhardwaj
Journal:  Mol Cancer Res       Date:  2017-04-25       Impact factor: 5.852

4.  Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7).

Authors:  Vladislav S Golubkov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

5.  Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.

Authors:  Manasa Ramakrishna; Louise H Williams; Samantha E Boyle; Jennifer L Bearfoot; Anita Sridhar; Terence P Speed; Kylie L Gorringe; Ian G Campbell
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

6.  Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines.

Authors:  Siina Junnila; Arto Kokkola; Marja-Liisa Karjalainen-Lindsberg; Pauli Puolakkainen; Outi Monni
Journal:  BMC Cancer       Date:  2010-03-01       Impact factor: 4.430

7.  Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway.

Authors:  Ling Meng; Kwame Sefah; Meghan B O'Donoghue; Guizhi Zhu; Dihua Shangguan; Afshan Noorali; Yan Chen; Lei Zhou; Weihong Tan
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

8.  Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer.

Authors:  Dariush Etemadmoghadam; Joshy George; Prue A Cowin; Carleen Cullinane; Maya Kansara; Kylie L Gorringe; Gordon K Smyth; David D L Bowtell
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

9.  The development of a mini-array for estimating the disease state of gastric adenocarcinoma by array CGH.

Authors:  Tomoko Furuya; Tetsuji Uchiyama; Atsushi Adachi; Takae Okada; Motonao Nakao; Atsunori Oga; Song-Ju Yang; Shigeto Kawauchi; Kohsuke Sasaki
Journal:  BMC Cancer       Date:  2008-12-30       Impact factor: 4.430

10.  Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.

Authors:  Subbareddy Maddika; Junjie Chen
Journal:  Nat Cell Biol       Date:  2009-03-15       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.